机器学习应用程序用于预测口服抗凝药治疗心房的患者的出血风险
Tsahi T Lerman1,2, Shmuel Tiosano3, Roy Beigel1,4
1School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Acta haematologica
|June 15, 2025
概括
机器学习 (ML) 改善了在接受抗凝药的心房动 (AF) 患者的出血风险预测. ML模型的性能优于传统的分数,提高了中风预防和华法林管理,以提高患者安全.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 人工智能在医学中的应用
背景情况:
- 心房动 (AF) 增加了中风风险,需要抗凝治疗.
- 抗凝剂增加出血风险,需要准确的出血风险分层.
- 传统的出血风险评分显示在不同AF群体中表现不佳.
研究的目的:
- 审查用于预测AF患者出血风险的机器学习 (ML) 应用程序.
- 探索ML在优化抗凝治疗和华法林管理中的作用.
- 突出ML在提高患者安全和治疗疗效方面的潜力.
主要方法:
- 审查最近在ML的进展,以预测出血风险.
- 在AF患者中基于ML的出血风险得分的分析.
- 检查ML在华法林剂量预测和相互作用识别中的应用.
主要成果:
- 与传统的出血风险得分相比,ML模型显示出更高的预测性能.
- ML利用复杂的数据集来识别出出血风险中的细微模式.
- 基于ML的工具显示了改善华法林管理和患者安全的潜力.
结论:
- 机器学习在预测AF患者出血风险方面取得了重大进展.
- 基于ML的工具可以优化抗凝治疗,改善患者的治疗结果.
- 进一步开发和验证ML应用对于临床实践至关重要.
更多相关视频
23:33The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.9K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.4K
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
27
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
27
